With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $14.00B. The average expense ratio is 0.76%. Biotech ETFs can be found in the following asset classes:
The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $6.99B in assets. In the last trailing year, the best performing Biotech ETF was the BBH at 13.37%. The most-recent ETF launched in the Biotech space was the Global X Genomics & Biotechnology ETF GNOM in 04/05/19.